OSTX
HealthcareOS Therapies Incorporated
$1.44
+$0.10 (+7.46%)
Jan 5, 2026
Price History (1Y)
Analysis
OS Therapies Incorporated operates in the healthcare sector within the biotechnology industry. The company's scale is modest, with a market capitalization of $50.71 million and a workforce consisting of only four employees. The financial health of OS Therapies Incorporated is concerning, as evidenced by its margins. The company has reported a gross margin, operating margin, and profit margin of 0.0% each. Additionally, the net income (TTM) stands at -$20,256,220. Returns on equity and assets are also negative, with ROE at -914.0% and ROA at -225.1%. The company's cash position is relatively small at $1.88 million, while debt information is not available. The valuation context of OS Therapies Incorporated is complex, with a forward P/E ratio of -4.33 and an EV/EBITDA ratio of -2.38. This suggests that the market has significant expectations for future performance, which may be challenging given the company's recent financial results.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About OS Therapies Incorporated
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.
Visit website →Key Statistics
- Market Cap
- $50.71M
- P/E Ratio
- N/A
- 52-Week High
- $7.00
- 52-Week Low
- $1.12
- Avg Volume
- 373.04K
Company Info
- Industry
- Biotechnology
- Exchange
- ASE
- Country
- United States
- Employees
- 4